Janux Therapeutics, Inc. (JANX)

Balance Sheet (Trailing)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Quarter Ending	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31
Cash & Equivalents	55.95	36.4	39.39	251.63	70.77	7.81	-	-	-	0.66
Short-Term Investments	306.07	339.38	348.12	142.57	0	0	-	-	-	0
Cash & Cash Equivalents	362.02	375.78	387.51	394.2	70.77	7.81	0	0	0	0.66
Cash Growth	411.55%	4709.69%	-	-	-	1087.39%	-	-	-	-
Receivables	0	0	0	0.38	0.38	8	-	-	-	0
Other Current Assets	2.64	1.24	2.08	2.04	0.26	0.25	-	-	-	0
Total Current Assets	364.65	377.02	389.59	396.61	71.41	16.06	-	-	-	0.66
Property, Plant & Equipment	2.79	1.6	1.36	0.22	0.16	0.16	-	-	-	0.02
Other Long-Term Assets	1.15	1.21	0.14	0	0.26	0	-	-	-	0
Total Long-Term Assets	3.94	2.81	1.5	0.22	0.41	0.16	-	-	-	0.02
Total Assets	368.6	379.82	391.08	396.82	71.82	16.22	-	-	-	0.68
Accounts Payable	1.94	2.46	3.61	0.35	0.86	0.43	-	-	-	0.27
Deferred Revenue	4.65	5.86	7.1	7.89	8	8	-	-	-	0
Current Debt	0.15	0.19	0.21	0	0	0	-	-	-	4
Other Current Liabilities	5.77	4.28	1.54	0.96	-1.96	-5.25	-	-	-	0.36
Total Current Liabilities	12.52	12.8	12.47	9.21	6.89	3.18	-	-	-	4.63
Long-Term Debt	0	0	0.02	0	0	0	-	-	-	0
Other Long-Term Liabilities	-	0.7	1.84	2.82	4.35	6.05	-	-	-	-
Total Long-Term Liabilities	0	0.7	1.86	2.82	4.35	6.05	-	-	-	0
Total Liabilities	12.52	13.5	14.33	12.03	11.24	9.23	-	-	-	4.63
Total Debt	0.15	0.19	0.24	0	0	0	-	-	-	4
Common Stock	418.47	414.01	410.72	408.01	0.25	0.1	0	0	0	0.01
Retained Earnings	-60.82	-47.41	-34	-23.23	-17.02	-14.74	-	-	-	-7.96
Comprehensive Income	-1.57	-0.27	0.02	0.02	0	0	-	-	-	0
Shareholders' Equity	356.08	366.33	376.75	384.8	-16.77	-14.64	-	-	-	-7.94
Total Liabilities and Equity	368.6	379.82	391.08	396.82	-5.53	-5.41	0	0	0	-3.32
Net Cash / Debt	361.86	375.59	387.27	394.2	70.77	7.81	0	0	0	-3.34
Net Cash / Debt Growth	411.33%	4707.21%	-	-	-	-	-	-	-	-
Net Cash Per Share	8.76	15.96	9.41	39.29	63.69	8.54	-	-	-	-4.99
Working Capital	352.14	364.22	377.12	387.4	64.51	12.88	-	-	-	-3.97
Book Value Per Share	8.62	15.57	9.16	38.35	-15.09	-15.99	-	-	-	-11.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).